Morgan Stanley Artivion, Inc. Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Artivion, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,318,660 shares of AORT stock, worth $100 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,318,660
Previous 2,260,438
2.58%
Holding current value
$100 Million
Previous $55.6 Million
29.79%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding AORT
# of Institutions
193Shares Held
40.1MCall Options Held
19.2KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$286 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.96MShares$128 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$121 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$120 Million3.82% of portfolio
-
Juniper Investment Company, LLC New York, NY2.09MShares$90.3 Million27.62% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.74B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...